The Therapeutic Goods Administration (TGA) has stated that from 1 July 2023, authorised psychiatrists will be able to prescribe MDMA for the treatment of post-traumatic stress disorder (PTSD) and psilocybin for treatment-resistant depression.
local_offerCharles Sturt UniversityHealthMedicine
Social
Explore the world of social